Latest News

  • Kalbe Support Commercialization of Researches

    Nutrigenomics and Probiotics

    Wednesday, February 24, 2021
    Kalbe Support Commercialization of Researches

    Jakarta, February 24, 2021 – PT Kalbe Farma Tbk (Kalbe) in collaboration with the Ministry of Research and Technology/National Research and Innovation Agency (Kemenristek/BRIN) held the second scientific discussion as a part of the series of socialization of the Ristek/BRIN Kalbe Science Awards 2021 (RKSA) program. The scientific discussions was held online with the first keynote speaker dr. Ida Gunawan, M.S.,Sp.GK(K), Clinical Nutritionist of RS Pondok Indah Puri Indah - RS Hermina Daan Mogot, also a Lecturer of Masters & Specialized program of the Clinical Nutrition Studies at the Faculty of Medicine of the University of Indonesia with the topic of the Application of the Nutrigenomics Results in The Pandemic.

  • KGBio and Genexine Signed Immuno-Oncology Drug License Agreement GX-17

    Thursday, February 18, 2021
    KGBio and Genexine Signed  Immuno-Oncology Drug License Agreement GX-17

    
    

    Jakarta, 18 February 2021, PT Kalbe Farma Tbk ("Kalbe") through its subsidiary PT Kalbe Genexine Biologics (KGBio) signed a license agreement with Genexine South Korea to develop and commercialize an immuno-oncology drug GX-I7 (Efineptakin Alpha), namely long-acting interleukin-7 which uses the Genexine hyFc technology platform. 

  • Kalbe Educates on Gastric Health

    Peel Through Gastric Acid Issues

    Thursday, February 18, 2021
    Kalbe Educates on Gastric Health

    Jakarta, February 18, 2021 – PT Kalbe Farma Tbk (Kalbe) held an educational event on health in collaboration with the Indonesian Gastroenterology Foundation (YGI).  The health education event is aiming to increase public awareness on prevention and medication of gastric acid issues, specifically gastric ulcer and GERD.  The theme of the education event is "Peel Through Gastric Acid Issues" with GERD as its topic.  Speakers on education are Prof. dr. Abdul Aziz Rani, SpPD, K-GEH; dr. Rabbinu Rangga Pribadi, SpPD and Apt. Netty Andriana, S.Farm. 

  • Kalbe's 2021 Business Expansion Strategy

    Monday, February 15, 2021
    Kalbe's 2021 Business Expansion Strategy

    The optimism to grow through product innovation and services also encourages PT Kalbe Farma Tbk (“Kalbe”) to continue conducting products and services innovation.  Kalbe continues to collaborate to produce products and services that can be utilized by the people and can contribute to Kalbe's business performance.

RSS
12345Last